4-(Morpholine-4-sulfonyl)-benzoic acid, 95.0%, 2.5g

4-Ethoxycarbonyl-2-methylphenylisothiocyanate, 98.0%, 5g

2-chloro-1-[1-(2,5-dichlorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]ethanone, 95.0%, 500mg

5-Bromo-4-cloro-3-indoxil-N-acetil-β-D-glucosaminida, 100 mg

4,5-Dichloro-3-methylthiophene-2-carboxylic acid, 95%, 100mg

(4-methoxyphenyl)(methylamino)acetic acid, 95.0%, 25g

4-(4-Bromophenyl)tetrahydro-2H-pyran, 95.0%, 5g

Tapón con vidrio hueco cónico estándar, 12/21, 10 Unidad(es)

Ethyl 2-iodo-4-(trifluoromethyl)benzoate, 95%, 250mg

(S)-4-Boc-6-Amino-[1,4]oxazepane, 98%, 5g

(R)-1-Boc-2-Azetidinemethanol, 95.0%, 100mg

3-cyano-1-methylpyridinium iodide, 1g

(2S,3S,4S,5R,6S)-6-[(4,6-dihydroxy-5-oxo-2-phenyl-5H-chromen-7-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid, 95%, 5g